Complex mechanisms of DPP-IV inhibitor action In order to explain the insulinotropic effects of DPP-IV inhibitors, mechanisms other than those that prevent GLP-1 degradation in the circulation have to be taken into account
For more detailed guidance on potential risks, see our guide on Jardiance or Ozempic safety page
50 mg/kg twice daily for 28 days raised oxidative muscle fibers and OXPHOS proteins
We therefore routinely pilot dilution factors prior to an experiment, even for kits we know well
Tzang 2025 (18 RCTs): overweight/obesity regains +5.63 kg while type 2 diabetes regains +2.03 kg but rebounds harder on blood-sugar control (HbA1c +0.65 vs +0.25%)
Many of the subcutaneous products are administered once weekly, which contributes to medication errors, as demonstrated in this study, where 8% of patients reported injecting the weekly medication daily